Galectin Therapeutics
GALT
#8191
Rank
NZ$0.29 B
Marketcap
$4.66
Share price
-3.37%
Change (1 day)
44.55%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$0.18 Billion

According to Galectin Therapeutics's latest financial reports the company's total liabilities are NZ$0.18 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$84.23 M46.73%
2021-12-31NZ$57.4 M666.06%
2020-12-31NZ$7.49 M75.73%
2019-12-31NZ$4.26 M35.7%
2018-12-31NZ$3.14 M-24.8%
2017-12-31NZ$4.17 M-23.42%
2016-12-31NZ$5.45 M174.62%
2015-12-31NZ$1.98 M-8.58%
2014-12-31NZ$2.17 M-28.15%
2013-12-31NZ$3.02 M51.38%
2012-12-31NZ$1.99 M-29.58%
2011-12-31NZ$2.83 M-72.61%
2010-12-31NZ$10.36 M53.5%
2009-12-31NZ$6.75 M233.96%
2008-12-31NZ$2.02 M-67.1%
2007-12-31NZ$6.14 M-32.21%
2006-12-31NZ$9.06 M348.89%
2005-12-31NZ$2.01 M43.35%
2004-12-31NZ$1.4 M142.21%
2003-12-31NZ$0.58 M-54.36%
2002-12-31NZ$1.27 M-3.93%
2001-12-31NZ$1.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.31 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.14 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA